Tochigi, Japan

Masataka Hanada

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 2017-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masataka Hanada. Retrieved from https://idiyas.com/inventor/masataka-hanada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Masataka Hanada: Pharmaceutical Formulation Inventor

Introduction

Masataka Hanada is an inventor associated with Kyorin Pharmaceutical Co., Ltd. and based in Tochigi, Japan. His patent work includes solid pharmaceutical compositions designed to support the release of medically active compounds. He is credited with 3 patents.

Latest Patents

Hanada’s listed recent patents concern solid pharmaceutical compositions and approaches to controlling the release of active compounds.

- **Solid pharmaceutical composition.** This invention addresses delayed release of a compound represented by general formula (1), or a salt thereof. The composition combines the compound or its salt with a salting-out agent.

- **Solid pharmaceutical composition.** This invention addresses delays in releasing a medically active component caused by gelling. The composition contains a compound represented by general formula (1), or a salt thereof, a cellulosic excipient, and a salting-out agent.

Career Highlights

Hanada’s patent portfolio reflects work on pharmaceutical formulation, particularly the design of solid compositions intended to manage release behavior. His listed inventions focus on using formulation ingredients to address delayed release.

Collaborations

Hanada’s listed coworkers include Hiroshi Uchida and Yoshikazu Miyazaki. His company affiliation is Kyorin Pharmaceutical Co., Ltd.

Conclusion

Masataka Hanada’s recorded patent work highlights formulation strategies for solid pharmaceuticals, with an emphasis on addressing delayed release and gelling-related release delays.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…